EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

New Glycotoxin Inhibitor from Sesuvium sesuvioides Mitigates Symptoms of Insulin Resistance and Diabetes by Suppressing AGE-RAGE Axis in Skeletal Muscle

Safina Ghaffar, Rizwana Sanaullah Waraich iD, Raha Orfali, Areej Al-Taweel, Hanan Y Aati iD, Sonia Kamran, Shagufta Perveen iD

Molecules · 2024

DOI: 10.3390/molecules29153649 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Safina Ghaffar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Research Center, Department of Biomedical & Biological Sciences, Sohail University, Karachi 78400, Pakistan. Hauptthemen laut MEDLINE: Insulin Resistance, Glycation End Products, Advanced, Diabetes Mellitus, Experimental, Muscle, Skeletal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University, S. M Sohail Trust, Sohail University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The current study intended to investigate the role of new natural compounds derived from the Sesuvium sesuvioides plant in mitigating symptoms of diabetes and insulin resistance in the diabetic mice model. Anti-advanced glycation activity, insulin, and adiponectin were quantified by enzyme-linked immunosorbent assay (ELISA). Glucose uptake was performed using enzymatic fluorescence assay, and glycogen synthesis was measured using PAS staining. Gene and protein expression was assessed using real time PCR (RT-PCR), and immunoblotting and fluorescent microscopy, respectively. The new flavonoid glycoside eupalitin 3-O-α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranoside 1 isolated from S. sesuvioides exhibited anti-AGE activity by reducing human glycated albumin in liver cells. In a diabetic mouse model treated with compound 1, we observed improved glucose tolerance, increased adiponectin levels, and decreased insulin resistance. We also observed alleviated AGEs induced reduction in glucose uptake and restored glycogen synthesis in the compound 1-treated diabetic mice muscles. Exploring the molecular mechanism of action in skeletal muscle tissue of diabetic mice, we found that 1 reduced AGE-induced reactive oxygen species and the inflammatory gene in the muscle of diabetic mice. Additionally, 1 exhibited these effects by reducing the gene and protein expression of receptor for advanced glycation end products (RAGE) and inhibiting protein kinase C (PKC) delta activation. This further led us to demonstrate that compound 1 reduced serine phosphorylation of IRS-1, thereby restoring insulin sensitivity. We conclude that a new flavonoid glycoside from S. sesuvioides could be a therapeutic target for the treatment of symptoms of insulin resistance and diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceGlycation End Products, AdvancedDiabetes Mellitus, ExperimentalMuscle, SkeletalReceptor for Advanced Glycation End ProductsAnimalsMiceHumansMaleGlycosides

Stichwörter der Autor:innen

advanced glycation end productsantidiabetic compoundinflammationoxidative stressreceptor for advance glycation end products

Substanzen

Glycation End Products, AdvancedReceptor for Advanced Glycation End ProductsGlycosides

Autor:innen und Institutionen

  • Biomedical Research Center, Department of Biomedical & Biological Sciences, Sohail University, Karachi 78400, Pakistan.
  • Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11495, Saudi Arabia.
  • Department of Chemistry, School of Computer, Mathematical and Natural Sciences, Morgan State University, Baltimore, MD 21251, USA.
  • Department of Bacteriology, University of Wisconsin-Madison, Madison, WI 53706, USA.

ORCID-Profile: Rizwana Sanaullah Waraich, Hanan Y Aati, Shagufta Perveen

Förderung

  • King Saud University
  • S. M Sohail Trust, Sohail University

Zitieren

APA

Ghaffar, S., Waraich, R. S., Orfali, R., Al-Taweel, A., Aati, H. Y., Kamran, S., & Perveen, S. (2024). New Glycotoxin Inhibitor from Sesuvium sesuvioides Mitigates Symptoms of Insulin Resistance and Diabetes by Suppressing AGE-RAGE Axis in Skeletal Muscle. Molecules. https://doi.org/10.3390/molecules29153649

Vancouver

Ghaffar S, Waraich RS, Orfali R, Al-Taweel A, Aati HY, Kamran S, et al. New Glycotoxin Inhibitor from Sesuvium sesuvioides Mitigates Symptoms of Insulin Resistance and Diabetes by Suppressing AGE-RAGE Axis in Skeletal Muscle. Molecules. 2024. doi:10.3390/molecules29153649

BibTeX
@article{Ghaffar2024,
  author = {Ghaffar, Safina and Waraich, Rizwana Sanaullah and Orfali, Raha and Al-Taweel, Areej and Aati, Hanan Y and Kamran, Sonia and Perveen, Shagufta},
  title = {New Glycotoxin Inhibitor from Sesuvium sesuvioides Mitigates Symptoms of Insulin Resistance and Diabetes by Suppressing AGE-RAGE Axis in Skeletal Muscle},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29153649}
}
Kostenlos starten →